Search Results
Mineralocorticoid Antagonism in Heart Failure | ESC 2024
ESC 24: MRAs in Heart Failure
Optimization of heart failure therapy: what's new from ESC Congress 2024?
NEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection Fraction
Time to Significant Benefit of Finerenone in Patients with Heart Failure | JACC | HFSA 2024
Finerenone in Heart Failure with Preserved Ejection Fraction | NEJM
Aldosterone Antagonists in Heart Failure
ESC 24: FINE-HEART: Finerenone in HF & CKD
Part 2: Time to Significant Benefit of Finerenone in Patients With Heart Failure | JACC | HFSA 2024
Mineralocorticoid Antagonists in CKD - Prof. P. Rossignol, Dr. L. A. Mortensen, Prof. M. Walsh
Mineralocorticoid Receptor Blockade and CVD: What's the Story?
2024 Heart Failure update: NICE guideline
